Immunology

Researchers pioneer new eczema treatment

Eczema is the most common and stubborn skin disease in the world, but a study led by Dr. Donald Leung of the University of Colorado Anschutz Medical Campus is offering new hope for those with atopic dermatitis.

Immunology

Researchers discover new source of skin defects in eczema

Researchers at National Jewish Health have discovered a cause of the dry, inflamed and itchy skin that plagues eczema patients. A team led by Donald Leung, MD, Ph.D., has shown that an immune system skewed toward allergy ...

Diseases, Conditions, Syndromes

Both narrowband UVB, psoralen UVA helpful for hand eczema

(HealthDay)—Both psoralen ultraviolet A (PUVA) and narrowband ultraviolet B (NBUVB) improve the severity of chronic palmar hand eczema, according to a pilot study published online Dec. 13 in the British Journal of Dermatology.

Immunology

Atopic eczema—one size does not fit all

Researchers from the UK and Netherlands have identified five distinct subgroups of eczema, a finding that helps explain how the condition can affect people at different stages of their lives.

Immunology

How the skin becomes inflamed

Publishing online this week in Cell Host & Microbe, researchers at Johns Hopkins report the discovery of a key underlying immune mechanism that explains why to how our skin becomes inflamed from conditions such as atopic ...

page 9 from 18